SONIRE THERAPEUTICS
Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
SONIRE THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical Wellness
Founded:
2020-02-01
Address:
Shinjuku, Yamanashi, Japan
Country:
Japan
Website Url:
http://www.sonire-therapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
530 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Scailyte
True precision medicine through single-cell science
Investors List
Japan Science and Technology Agency
Japan Science and Technology Agency investment in Series A - Sonire Therapeutics
MAKOTO Capital
MAKOTO Capital investment in Series A - Sonire Therapeutics
Fukuoka Financial Group
Fukuoka Financial Group investment in Series A - Sonire Therapeutics
SBI Investment
SBI Investment investment in Series A - Sonire Therapeutics
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series A - Sonire Therapeutics
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series A - Sonire Therapeutics
Higin Capital
Higin Capital investment in Series A - Sonire Therapeutics
epiST
epiST investment in Series A - Sonire Therapeutics
Official Site Inspections
http://www.sonire-therapeutics.com
- Host name: www21.gmoserver.jp
- IP address: 133.130.64.184
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Sonire Therapeutics"
集束超音波 (HIFU：ハイフ)治療 - SONIRE Therapeutics
SONIRE Therapeutics Inc. Board members President & CEO：Tohru Satoh Vice President & COO：Jun Okamoto Vice President & CFO：Naoki Kobayashi External Board …See details»
Sonire Therapeutics - Crunchbase Company Profile & Funding
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) …See details»
Sonire Therapeutics Company Profile 2024: Valuation, Funding ...
Sonire Therapeutics has raised $21.8M. Who are Sonire Therapeutics’s investors? MedTech Innovator , Carbon Ventures , Daiwa Corporate Investment , JA Mitsui Leasing, and Japan …See details»
Interviews with leading Life Sciences companies: Sonire …
Aug 30, 2023 Sonire Therapeutics has commenced a randomized Phase 2 study for the treatment of unresectable pancreatic cancer with their next-generation High-Intensity Focused Ultrasound therapy system. Learn more …See details»
SONIRE Therapeutics Inc. | J-Startup
SONIRE Therapeutics Inc. is developing a next-generation ultrasound-guided HIFU therapy system based on the technology and know-how developed at Tokyo Women’s Medical …See details»
SONIRE Therapeutics Inc. - LinkedIn
SONIRE Therapeutics Inc. (SONIRE) is developing a next-generation high-intensity focused ultrasound (HIFU) treatment system that uses acoustic engineering (ultrasound) technology …See details»
Sonire Therapeutics Inc. | NEDO
Phase Business Area/Field Research Period Research Grant Amount; PCA: Healthcare: 22023 - 2025FY: JPY 971 millionSee details»
SONIRE Therapeutics Inc. | Global Startup Acceleration Program …
SONIRE has been developing the next-generation HIFU therapy system as a new treatment modality targeting at intractable cancers like pancreatic cancer using the technology and …See details»
Sonire Therapeutics - Funding, Financials, Valuation & Investors
Sonire Therapeutics provides high-intensity focused ultrasound treatment for cancer. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...See details»
Company Profile: SONIRE Therapeutics - Focused …
Feb 22, 2023 SONIRE Therapeutics Inc. is headquartered in Tokyo, Japan, and has just announced a new clinical trial assessing their novel focused ultrasound device for the treatment of unresectable pancreatic cancer. We spoke with the …See details»
SONIRE Therapeutics - Company Profile - Tracxn
Nov 14, 2024 SONIRE Therapeutics ranks 7th among 19 active competitors. 5 of its competitors are funded while 2 have exited. Overall, SONIRE Therapeutics and its competitors have raised …See details»
To all: Sep 8th, 2023 SONIRE Therapeutics Inc.
SONIRE Therapeutics Inc. Notice of Adoption being seleced for “Deep Tech Startup Support Program” by New Energy and Industrial Technology Development Organization (NEDO) …See details»
SONIRE’s HIFU Therapy System Designated as Breakthrough
TOKYO, Oct. 16, 2024 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as “SONIRE”), based in Tokyo, Japan, announces that its self-developed next-generation HIFU …See details»
SONIRE's HIFU therapy system has been designated as a …
SONIRE Therapeutics Inc. (Headquarters: Tokyo, Japan; President and CEO, Founder: Tohru Satoh; hereinafter referred to as "SONIRE"), announces that the next-generation HIFU (High …See details»
FDA Grants Breakthrough Device Designation for Emerging High …
Oct 16, 2024 The Food and Drug Administration (FDA) has issued a breakthrough device designation to Sonire Therapeutics for the use of its high-intensity focused ultrasound (HIFU) …See details»
SONIRE's HIFU Therapy System Designated as Breakthrough …
TOKYO, Oct. 16, 2024 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, Japan, announces that its self-developed next-generation HIFU …See details»
Announcement of approximately JPY 530 million in Series A funding
SONIRE Therapeutics Inc. Announcement of approximately JPY 530 million in Series A funding SONIRE Therapeutics Inc. (Head office: Shinjuku, Tokyo. ... Organization). We will continue to …See details»
SONIRE's Advanced HIFU System Receives FDA Breakthrough Status
Oct 16, 2024 SONIRE Therapeutics Inc., a leading innovator in healthcare technology, has exciting news to share regarding its next-generation High-Intensity Focused Ultrasound (HIFU) …See details»
Press Release SONIRE Therapeutics CEO Tohru Satoh to speak at …
SONIRE Therapeutics CEO Tohru Satoh to speak at MEDICA 2024 SONIRE Therapeutics Inc. (Headquarters: Tokyo, Japan; President and CEO, Founder: Tohru Satoh; hereinafter referred …See details»